FDA Approves Pizensy (lactitol) for the Treatment of Chronic Idiopathic Constipation in Adults
Braintree, Mass. March 02, 2020 -- Sebela Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved Pizensy (lactitol) for oral solution for the once-daily treatment of chronic idiopathic constipation (CIC)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news